There was also a higher frequency of CD8+perforin+ T cells in RCC patients compared to normal healthy donors (27.58 vs. 15.25%, p = 0.020) and a trend towards decreasing CD8+perforin+ T cells in patients with progressive disease (Fig. 2B). This evidence concerns the gene CD8A and renal cell carcinoma.